Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,165 | 188 | 99.6% |
| Education | $14.00 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $350.79 | 22 | $0 (2024) |
| Amgen Inc. | $331.66 | 13 | $0 (2022) |
| ABBVIE INC. | $277.41 | 10 | $0 (2024) |
| Merck Sharp & Dohme LLC | $221.14 | 17 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $207.08 | 15 | $0 (2022) |
| GlaxoSmithKline, LLC. | $193.81 | 12 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $164.71 | 12 | $0 (2024) |
| Novo Nordisk Inc | $159.45 | 10 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $130.99 | 8 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $126.14 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $471.23 | 24 | Lilly USA, LLC ($110.94) |
| 2023 | $735.58 | 40 | Lilly USA, LLC ($150.98) |
| 2022 | $364.02 | 21 | AstraZeneca Pharmaceuticals LP ($59.44) |
| 2020 | $120.09 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($39.64) |
| 2019 | $400.36 | 30 | Merck Sharp & Dohme Corporation ($110.24) |
| 2018 | $541.36 | 32 | Amgen Inc. ($169.19) |
| 2017 | $545.94 | 35 | Amgen Inc. ($134.93) |
All Payment Transactions
190 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $20.81 | General |
| Category: Cranial Orthotic | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: VACCINES | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: VACCINES | ||||||
| 10/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Endocrinology | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardio-renal | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: RESPIRATORY | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.23 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Diabetes | ||||||
| 04/23/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Oncology | ||||||
| 03/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Diabetes Care | ||||||
| 03/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Gastroenterology | ||||||
| 02/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.74 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Diabetes | ||||||
| 02/08/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Diabetes | ||||||
| 01/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: PSYCHIATRY | ||||||
| 01/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Diabetes | ||||||
| 12/22/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 120 | 158 | $27,430 | $12,198 |
| 2022 | 8 | 156 | 228 | $28,584 | $13,664 |
| 2021 | 17 | 673 | 957 | $87,548 | $34,815 |
| 2020 | 15 | 830 | 1,287 | $128,859 | $41,424 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 52 | $10,591 | $4,350 | 41.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 29 | $8,189 | $3,234 | 39.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 23 | 23 | $4,945 | $2,991 | 60.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 21 | $2,999 | $1,178 | 39.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 17 | 17 | $578.00 | $320.11 | 55.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 16 | $128.00 | $125.44 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 57 | $11,514 | $4,642 | 40.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 28 | $7,588 | $3,589 | 47.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 21 | 21 | $4,515 | $2,793 | 61.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 19 | $2,641 | $1,054 | 39.9% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 11 | 11 | $759.00 | $743.82 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $451.00 | $332.53 | 73.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 18 | 18 | $612.00 | $326.31 | 53.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 32 | 63 | $504.00 | $184.53 | 36.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 85 | 182 | $34,580 | $10,310 | 29.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 60 | 60 | $11,820 | $8,134 | 68.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 68 | 79 | $20,066 | $5,613 | 28.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 56 | $7,280 | $2,508 | 34.5% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 22 | 22 | $1,518 | $1,431 | 94.3% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 33 | 33 | $1,353 | $1,136 | 84.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 56 | 56 | $1,680 | $1,083 | 64.5% |
| 0064A | Fee covid-19 vac 7 res | Office | 2021 | 26 | 26 | $1,066 | $1,066 | 100.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 16 | 16 | $1,040 | $1,040 | 100.0% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 34 | 34 | $1,394 | $783.78 | 56.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 39 | 39 | $1,599 | $683.28 | 42.7% |
About Dr. Robert Haskins, MD
Dr. Robert Haskins, MD is a Family Medicine healthcare provider based in Greeley, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487629390.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Haskins, MD has received a total of $3,179 in payments from pharmaceutical and medical device companies, with $471.23 received in 2024. These payments were reported across 190 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($3,165).
As a Medicare-enrolled provider, Haskins has provided services to 1,779 Medicare beneficiaries, totaling 2,630 services with total Medicare billing of $102,102. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Greeley, CO
- Active Since 02/22/2006
- Last Updated 03/24/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487629390
Products in Payments
- VRAYLAR (Drug) $246.63
- Repatha (Biological) $199.83
- JARDIANCE (Drug) $183.11
- FARXIGA (Drug) $167.54
- Kerendia (Drug) $164.71
- MOUNJARO (Drug) $140.36
- JANUVIA (Drug) $127.11
- Prolia (Biological) $103.90
- XARELTO (Drug) $89.51
- TRULICITY (Drug) $88.87
- Cologuard Collection Kit (Device) $81.00
- ENTRESTO (Drug) $78.94
- BEXSERO (Biological) $76.95
- Rybelsus (Drug) $67.47
- FREESTYLE LIBRE 3 (Device) $63.54
- LO LOESTRIN FE (Drug) $62.44
- XIFAXAN (Drug) $59.14
- NURTEC ODT (Drug) $58.06
- QULIPTA (Drug) $50.80
- Ozempic (Drug) $49.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Greeley
Joy Ruff, M.d, M.D
Family Medicine — Payments: $44,700
Dr. Chima Nwizu, Md, MD
Family Medicine — Payments: $6,387
Dr. Gregory Denzel, Do, DO
Family Medicine — Payments: $5,085
Dr. Donald Wilson, Md, MD
Family Medicine — Payments: $4,831
Kyle Waugh, Md, MD
Family Medicine — Payments: $3,127
Erin Morley, M.d, M.D
Family Medicine — Payments: $2,848